[Cyproterone acetate. Its value in the treatment of prostatic cancer. Apropos of 45 cases].
Tobelem
G
G
Arvis
G
G
D000135:Acid Phosphatase / Q000097:blood; D000726:Androgen Antagonists / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy; D011877:Radionuclide Imaging; D012189:Retrospective Studies
D000726:Androgen Antagonists; D017373:Cyproterone Acetate; D003534:Cyproterone; D000135:Acid Phosphatase
L'acétate de cyprotérone. Son intérêt dans le traitement du cancer prostatique. A propos de 45 cas.